No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Life-Saving CAE Air1 Ventilator Receives Health Canada Certification

Editor: What To Know

  •  “The agility shown by CAE in designing and succeeding to have the CAE Air1 ventilator certified in a fraction of the usual time is a testament to the strength of CAE’s innovation, engineering talent, and advanced manufacturing capabilities.
  • I am glad that we were able to support CAE in accelerating the design and manufacturing of CAE Air1 ventilator that is now ready to be used by our frontline healthcare workers,”.
  • CAE Air1 ventilator is made-in-Canada ventilator is destined for hospitals across the country where it will be used in the fight against COVID-19.

CAE Air1 ventilator has been certified by Health Canada. The news was announced today by CAE.

CAE Air1 ventilator is made-in-Canada ventilator is destined for hospitals across the country where it will be used in the fight against COVID-19.

Certification comes two months after CAE signed a contract with the Government of Canada to manufacture and supply 10,000 ventilators.

“Since the beginning of the pandemic, CAE was the first to receive certification from Health Canada for an entirely new ventilator. It was created and manufactured in Canada, and we are proud that it will help save lives in the fight against COVID-19,” said Marc Parent, CAE’s President and CEO. “The agility shown by CAE in designing and succeeding to have the CAE Air1 ventilator certified in a fraction of the usual time is a testament to the strength of CAE’s innovation, engineering talent, and advanced manufacturing capabilities. I am proud of our team for rising to this humanitarian challenge and strengthening Canada’s self-sufficiency in the medical field during these unprecedented times.”

CAE will now start shipping hundreds of CAE Air1 ventilators to the Government of Canada every week. The CAE Air1 ventilator can deliver pressure control, volume control and pressure support ventilation using room air or pressured oxygen. It uses an intuitive, simple touchscreen interface and is bundled with on-demand ventilator training, adaptive e-learning modules related to COVID-19 patient management, and 24/7 customer support. It will support Intensive Care Units patients treated for COVID-19.

“CAE, one of Canada’s leading aerospace firms, stepped up early on with their commitment to produce a made-in-Canada ventilator design that will help save the lives of COVID-19 patients battling the disease. Today’s announcement is a testament to CAE’s agility and innovative capability. I am glad that we were able to support CAE in accelerating the design and manufacturing of CAE Air1 ventilator that is now ready to be used by our frontline healthcare workers,” said the Honourable Navdeep Bains, Canada’s Minister of Innovation, Science and Industry.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy